Standout Papers

Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advance... 2016 2026 2019 2022 629
  1. Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non–Small-Cell Lung Cancer (2016)
    Geoffrey R. Oxnard, Kenneth S. Thress et al. Journal of Clinical Oncology
  2. Prospective Validation of Rapid Plasma Genotyping for the Detection ofEGFRandKRASMutations in Advanced Lung Cancer (2016)
    Adrian G. Sacher, Cloud P. Paweletz et al. JAMA Oncology

Immediate Impact

8 from Science/Nature 73 standout
Sub-graph 1 of 19

Citing Papers

Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
17 intermediate papers

Works of Ryan S. Alden being referenced

Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non–Small-Cell Lung Cancer
2016 Standout
Prospective Validation of Rapid Plasma Genotyping for the Detection ofEGFRandKRASMutations in Advanced Lung Cancer
2016 Standout
and 3 more

Author Peers

Author Last Decade Papers Cites
Ryan S. Alden 1163 1026 704 14 1.5k
Nora Feeney 1108 948 760 11 1.5k
Tan Min Chin 736 1219 677 14 1.6k
AmirAli Talasaz 669 946 612 13 1.2k
Oliver A. Zill 838 1225 703 24 1.8k
Stacy L. Mach 1063 1032 649 13 1.5k
Alvin Wong 790 1130 895 37 1.8k
Tsveta Milenkova 894 543 986 30 1.5k
A Piskorz 650 1036 538 6 1.3k
John Jiang 498 605 718 17 1.2k
Allison O’Connell 919 1039 647 9 1.4k

All Works

Loading papers...

Rankless by CCL
2026